These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17960327)

  • 21. Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease.
    Marinho EM; Batista de Andrade Neto J; Silva J; Rocha da Silva C; Cavalcanti BC; Marinho ES; Nobre Júnior HV
    Microb Pathog; 2020 Nov; 148():104365. PubMed ID: 32619669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the Sn binding pockets in gingipains by newly developed inhibitors: structure-based design, chemistry, and activity.
    Białas A; Grembecka J; Krowarsch D; Otlewski J; Potempa J; Mucha A
    J Med Chem; 2006 Mar; 49(5):1744-53. PubMed ID: 16509589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling of babesipain-1 and identification of natural and synthetic leads for bovine babesiosis drug development.
    Meetei PA; Rathore RS; Prabhu NP; Vindal V
    J Mol Model; 2016 Apr; 22(4):71. PubMed ID: 26969677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of vaccinia virus temperature-sensitive I7L mutants reveals two potential functional domains.
    Moerdyk MJ; Byrd CM; Hruby DE
    Virol J; 2006 Aug; 3():64. PubMed ID: 16945137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.
    Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST
    J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New class of orthopoxvirus antiviral drugs that block viral maturation.
    Byrd CM; Bolken TC; Mjalli AM; Arimilli MN; Andrews RC; Rothlein R; Andrea T; Rao M; Owens KL; Hruby DE
    J Virol; 2004 Nov; 78(22):12147-56. PubMed ID: 15507601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity.
    Shiryaev VA; Skomorohov MY; Leonova MV; Bormotov NI; Serova OA; Shishkina LN; Agafonov AP; Maksyutov RA; Klimochkin YN
    Eur J Med Chem; 2021 Oct; 221():113485. PubMed ID: 33965861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
    Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
    Wanga QM; Chen SH
    Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
    Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J
    Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A technique to study molecular recognition in drug design: preliminary application of free energy derivatives to inhibition of a malarial cysteine protease.
    Cieplak P; Kollman PA
    J Mol Recognit; 1996; 9(2):103-12. PubMed ID: 8877800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
    Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
    Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of whole genome sequence data on drug discovery--a malaria case study.
    Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
    Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural studies of cysteine proteases and their inhibitors.
    Grzonka Z; Jankowska E; Kasprzykowski F; Kasprzykowska R; Lankiewicz L; Wiczk W; Wieczerzak E; Ciarkowski J; Drabik P; Janowski R; Kozak M; Jaskólski M; Grubb A
    Acta Biochim Pol; 2001; 48(1):1-20. PubMed ID: 11440158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitors.
    Rigden DJ; Mosolov VV; Galperin MY
    Protein Sci; 2002 Aug; 11(8):1971-7. PubMed ID: 12142451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design.
    Zhang XW; Yap YL
    Bioorg Med Chem; 2004 May; 12(9):2219-23. PubMed ID: 15080921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of wide-spectrum inhibitors targeting coronavirus main proteases.
    Yang H; Xie W; Xue X; Yang K; Ma J; Liang W; Zhao Q; Zhou Z; Pei D; Ziebuhr J; Hilgenfeld R; Yuen KY; Wong L; Gao G; Chen S; Chen Z; Ma D; Bartlam M; Rao Z
    PLoS Biol; 2005 Oct; 3(10):e324. PubMed ID: 16128623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents.
    Karypidou K; Ribone SR; Quevedo MA; Persoons L; Pannecouque C; Helsen C; Claessens F; Dehaen W
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3472-3476. PubMed ID: 30286952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements.
    Webber SE; Okano K; Little TL; Reich SH; Xin Y; Fuhrman SA; Matthews DA; Love RA; Hendrickson TF; Patick AK; Meador JW; Ferre RA; Brown EL; Ford CE; Binford SL; Worland ST
    J Med Chem; 1998 Jul; 41(15):2786-805. PubMed ID: 9667969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.